One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis—A Case Series Report

One-year outcomes after therapy with ledipasvir/sofosbuvir (LDV/SOF) in children with chronic hepatitis C (CHC) presenting with and without significant liver fibrosis were analyzed. We included patients aged 12–17 years treated with LDV/SOF, presenting with significant fibrosis (F ≥ 2 on the METAVIR...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokorska-Śpiewak, Maria, Dobrzeniecka, Anna, Marczyńska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402679/
https://www.ncbi.nlm.nih.gov/pubmed/34452383
http://dx.doi.org/10.3390/v13081518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402679/
https://www.ncbi.nlm.nih.gov/pubmed/34452383
http://dx.doi.org/10.3390/v13081518

Ejemplares similares